Immunological Studies of Reactive Oxygen Species Damaged Catalase in Patients with Systemic Lupus Erythematosus: Correlation with Disease Activity Index

REFERENCES

• Al-Shobaili, H. A., Al Robaee, A., Alzolibani, A., Khan, M. I., Rasheed, Z. (2011). Hydroxyl radical modification of immunoglobulin g generated cross-reactive antibodies: its potential role in systemic lupus erythematosus. Clin. Med. Insights Arthritis Musculoskelet. Disord. 4: 11–19.
   Google Scholar
• Al-Shobaili, H. A., Al Robaee, A., Alzolibani, A. A., Rasheed, Z. (2012). Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: Role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis. Markers 33:19–34.
   PubMed Web of Science ®Google Scholar
• Ghaly, M. S., Ghattas, M. H., Labib, S. M. (2012). Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt. Lupus 21: 1244–1249.
   PubMed Web of Science ®Google Scholar
• Goyal, M. M., Basak, A. 2010. Human catalase: looking for complete identity. Protein Cell 1: 888–897.
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 40: 1725–1734.
   PubMed Web of Science ®Google Scholar
• Hwang, I., Lee, J., Huh, J. Y., Park, J., Lee, H. B., Ho, Y. S., Ha, H. (2012). Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61: 728–738.
   PubMed Web of Science ®Google Scholar
• Khan, M. F., Wu, X., Ansari, G. A. (2001). Anti-malondialdehyde antibodies in MRL+/+ mice treated with trichloroethene and dichloroacetyl chloride: possible role of lipid peroxidation in autoimmunity. Toxicol. Appl. Pharmacol. 170:s 88–92.
   Google Scholar
• Levine, R. L., Wehr, N., Williams, J. A., Stadtman, E. R., Shacter, E. (2000). Determination of carbonyl groups in oxidized proteins. Meth. Mol. Biol. 99: 15–24.
   PubMedGoogle Scholar
• Mansour, R. B., Lassoued, S., Gargouri, B., El Gaid, A., Attia, H., Fakhfakh, F. (2008). Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Rheumatol. 37: 103–108.
   PubMed Web of Science ®Google Scholar
• Manzi, S., Sánchez-Guerrero, J., Merrill, J. T., Furie, R., Gladman, D., Navarra, S. V., Ginzler, E. M., D’Cruz, D. P., Doria, A., Cooper S., Zhong, Z. J., Hough, D., Freimuth, W., Petri, M. A. (2012). Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann. Rheum. Dis. 71: 1833–1838.
   PubMed Web of Science ®Google Scholar
• Morgan, P. E., Sturgess, A. D., Hennessy, A., Davies, M. J. (2007). Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radic. Res. 41: 1301–1312.
   PubMed Web of Science ®Google Scholar
• Nadif, R., Mintz, M., Jedlicka, A., Bertrand, J. P., Kleeberger, S. R., Kauffmann, F. (2005). Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic. Res. 39: 1345–1350.
   PubMed Web of Science ®Google Scholar
• Norheim, K. B., Jonsson, G., Harboe, E., Hanasand, M., Goransson, L., Omdal, R. (2012). Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren’s syndrome. Free Radic. Res. 46: 141–146.
   PubMed Web of Science ®Google Scholar
• Otaki, N., Chikazawa, M., Nagae, R., Shimozu, Y., Shibata, T., Ito, S., Takasaki, Y., Fujii, J., Uchida, K. (2010). Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies. J. Biol. Chem. 29: 33834–33842.
   Google Scholar
• Poon, H. F., Vaishnav, R. A., Gelchell, T. V., Getchell, M. L., Butterfield, D. A. (2006). Quantitative proteomics analysis of differential protein expression and oxidative modification of specific proteins in the brains of old mice. Neurobiol. Aging 27: 1010‐9.
   PubMedGoogle Scholar
• Rasheed, Z. (2008). Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: Biochemical and immunological studies. Clin. Biochem. 41: 663–669.
   PubMed Web of Science ®Google Scholar
• Rasheed, Z., Ahmad, R., Rasheed, N., Ali, R. (2007). Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 40: 512–520.
   PubMed Web of Science ®Google Scholar
• Rasheed, Z., Ali, R. (2006). Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: Biochemical and immunological studies. Life Sci. 79: 2320–2328.
   PubMed Web of Science ®Google Scholar
• Rasheed, Z., Al-Shobaili, H. A., Al Robaee, A. A., Alzolibani, A. A., Wadi, W. I., Khan, M. I., Al-Hamed, H. A. (2012). Preferential recognition of peroxynitrite damaged thymidine-monophosphate by Anti-DNA autoantibodies in systemic lupus erythematosus. Nucleosides Nucleotides Nucl. Acids 31: 736–751.
   PubMed Web of Science ®Google Scholar
• Rasheed, Z., Al-Shobaili, H. A., Alzolibani, A. A., Ismail Khan, M., Ayub, T., Khan, M. I., Rasheed, N. (2011). Immunological functions of oxidized human immunoglobulin G in type 1diabetes mellitus: its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis. Markers 31: 47–54.
   PubMed Web of Science ®Google Scholar
• Rasheed, Z., Khan, M. W., Ali, R. (2006). Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Autoimmunity 39: 479–488.
   PubMed Web of Science ®Google Scholar
• Schmid, F. X. (1997). Optical spectroscopy to characterize protein conformation and conformational changes. In: Creighton, T. E. Ed., Protein Structure: A Practical Approach. Oxford: IRL Press, pp. 261–297.
   Google Scholar
• Scofield, R. H., Kurien, B. T., Ganick, S., McClain, M. T., Pye, Q., James, J. A., Schneider, R. I., Broyles, R. H., Bachmann, M., Hensley, K. 2005. Modification of lupus-associated 60-KDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic. Biol. Med. 38: 719–728.
   PubMed Web of Science ®Google Scholar
• Stadtman, E. R., Levine, R. L. (2000). Protein oxidation. Ann. NY Acad. Sci. 899: 191–208.
   PubMed Web of Science ®Google Scholar
• Warchol, T., Lianeri, M., Wudarski, M., Lacki, J., Jagodzinski, P. (2008). Catalase ‐262C>T polymorphism in systemic lupus erythomatosus in Poland. Rheumatol. Int. 28: 1035–1039.
   Google Scholar
• Wiesik-Szewczyk, E., Lacki, J. K., Feleszko, W., Olesinska M. (2010). Target therapies in systemic lupus erythematosus: current state of the art. Mini Rev. Med. Chem. 10:956–65.
   Google Scholar
• Zhang, Q., Ye, D. Q., Chen, G. P., Zheng, Y. 2010. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin. Exp. Dermatol. 35: 287–294.
   PubMedGoogle Scholar